Plasma Testosterone and Sexual Function in Men Receiving Buprenorphine Maintenance for Opioid Dependence
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
High-dose methadone is well known to cause testosterone deficiency and sexual dysfunction in opioid-dependent men. Buprenorphine is a new drug for the pharmacotherapy of opioid dependence. Its influence on the gonadal axis has not been investigated to date. We therefore assayed testosterone, free testosterone, estradiol, SHBG, LH, FSH, and prolactin in 17 men treated with buprenorphine. Thirty-seven men treated with high-dose methadone and 51 healthy blood donors served as controls. Sexual function and depression were assessed using a self-rating sexual function questionnaire and the Beck Depression Inventory. Patients treated with buprenorphine had a significantly higher testosterone level [5.1 +/- 1.2 ng/ml (17.7 +/- 4.2 nmol/liter) vs. 2.8 +/- 1.2 ng/ml (9.7 +/- 4.2 nmol/liter); P < 0.0001] and a significantly lower frequency of sexual dysfunction (P < 0.0001) compared with patients treated with methadone. The testosterone level of buprenorphine-treated patients did not differ from that of healthy controls. In conclusion, we demonstrated for the first time that buprenorphine, in contrast with high-dose methadone, seems not to suppress plasma testosterone in heroin-addicted men. To this effect, buprenorphine was less frequently related to sexual side effects. Buprenorphine might therefore be favored in the treatment of opioid dependence to prevent patients from the clinical consequences of methadone-induced hypogonadism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Buprenorphine, a partial opioid receptor agonist, is associated with milder effects on the hypothalamic-pituitary-gonadal system (91,92).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [91]
In the citing paper
“In patients on methadone or buprenorphine maintenance treatment, PRL has been found to be reduced, similar, or higher when compared with controls (91,150,151).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [91]
Citations
Cites
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480200058024 · Cited by 572
Function of the Male Sex Organs in Heroin and Methadone Users
Cicero, T. J., Bell, R. D., Wiest, W. G., Allison, J. H., Polakoski, K., & Robins, E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504242921703 · Cited by 246
Buprenorphine: how to use it right
JOHNSON, R. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00060-7 · Cited by 241
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic
WALSH, S. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00056-5 · Cited by 219
Plasma testosterone levels in heroin addiction and during methadone maintenance.
Mendelson, J. H., Mendelson, J. E., & Patch, V. D. (1975) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30047-9 · Cited by 148
Decreased serum testosterone concentration in male heroin and methadone addicts
Azizi, F., Vagenakis, A. G., Longcope, C., Ingbar, S. H., & Braverman, L. E. (1973) · Steroids · doi:10.1016/0039-128x(73)90002-0 · Cited by 130
Clinical efficacy of buprenorphine: comparisons to methadone and placebo
LING, W. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00059-0 · Cited by 121
Opioid-induced suppression of rat testicular function.
Adams, M. L., Sewing, B., Forman, J. B., Meyer, E. R., & Cicero, T. J. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38343-6 · Cited by 87
Cited by
Items 101–200 of 258
Hejazian, S. H., Dashti, M. H., & Rafati, A. (2007) · TSpace (University of Toronto) · Cited by 19
Spinal pain: current understanding, trends, and the future of care
Parkin-Smith, G. F., Amorin-Woods, L., Davies, S., Losco, B. E., & Adams, J. (2015) · Journal of Pain Research · doi:10.2147/jpr.s55600 · Cited by 18
“…is audited) is the least harmful effective option 82,83 as it is the only strong opioid not associated with rapid tolerance, opioid-induced hyperalgesia, 84 lowering of the person’s sex hormones, 85 or a negative impact on the patient’s immune system via inhibiting their natural killer cells.”
Yee, A. H. A., Loh, H. S., Loh, H. H., Riahi, S., Ng, C. G., & bin Sulaiman, A. H. (2019) · Annals of General Psychiatry · doi:10.1186/s12991-019-0249-z · Cited by 18
Ramli, F. F., Syed Hashim, S. A., & Mohd Effendy, N. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.52201 · Cited by 17
“Gotthardt et al. [10] conducted a study in the OST population that consisted of MMT, BMT, and morphine sulfate replacement therapy patients.”
BackgroundInfluentialChehrei, S., Moradi, M., Ghiabi, H., Falahi, M., Kaviani, S., & Ghanbari, A. (2016) · Andrologia · doi:10.1111/and.12749 · Cited by 17
“previously have represented in male rats (Bliesener et al., 2005; Cicero, Davis, LaRegina, Meyer, & Schlegel, 2002; Moradi et al., 2015; SokolowskaMikolajczyk, Socha, & Mikolajczyk, 2005).”
BackgroundInfluentialThe Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine
Lim, S. C. B., Schug, S. A., & Krishnarajah, J. (2017) · Pain Medicine · doi:10.1093/pm/pnx321 · Cited by 17
Prolactin receptor and osteogenic induction of prolactin in human periodontal ligament fibroblasts
Surarit, R., Krishnamra, N., & Seriwatanachai, D. (2016) · Cell Biology International · doi:10.1002/cbin.10580 · Cited by 16
“The results thus implied that the 10 ng/mL PRL, which was comparable to the basal plasma levels in male and non-pregnant female rodents (Jacobs et al., 1972; Bliesener et al., 2005), did have a functional role in PDL differentiation and osteogenesis in normal mammals.”
Madrid, L. B., Morel, S., Ndiaye, K., Mezaache, S., Castro, D. R., Mora, M., Olivet, F., Laporte, V., Protopopescu, C., Carrieri, P., et al. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.05.030 · Cited by 16
“buprenorphine - a partial-opioid agonist - and testosterone levels, has not been clearly established, as many results are contradictory (Bliesener et al., 2005; Gulliford, 1998; Hallinan et al., 2009).”
BackgroundResultImpact of opioid therapy on gonadal hormones: focus on buprenorphine
Varma, A., Sapra, M., & Iranmanesh, A. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0080 · Cited by 15
“[17] used a two question self-rating scale along with hormonal assays (testosterone, SHBG, free testosterone, estradiol, LH, FSH and prolactin) and found that, in contrast to methadone, buprenorphine at a dose of 8–20 mg/day did not suppress plasma testosterone in heroin addicted men when compared to normal healthy co…”
BackgroundMethodHealth-Seeking Behavior for Erectile Dysfunction in Methadone Maintenance Treatment Patients
Ramli, F. F., Shuid, A. N., Mohamed, R. M. P., Sidik, T. M. I. T. A. B., & Mohamed, I. N. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16214249 · Cited by 15
“[8] showed that MMT patients had profoundly lower testosterone levels and higher levels of sexual dysfunction (in terms of libido and potency) as compared to a buprenorphine maintenance treatment (BMT) group.”
BackgroundResultExogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Bakare, T. T., Uzoeto, H. O., Gonlepa, L. N., Cosmas, S., Ajima, J. N., Arazu, A. V., Ezechukwu, S. P., Didiugwu, C. M., Ibiang, G. O., Osotuyi, A. G., et al. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03207-1 · Cited by 14
“…luteinizing hormone (LH) [65], estrogen (estradiol, etc.) [65, 71], cortisol [62, 72], corticotropin-releasing hormone (CRH) [62, 72], adrenocorticotropin (ACTH), dehydroepiandrosterone sulfates (DHEAS) and dehydroepian-drosterone (DHEA) [58], as well as testosterone (both total and free) [73, 74].”
Change in symptoms of erectile dysfunction in depressed men initiating buprenorphine therapy
Cioe, P. A., Anderson, B. J., & Stein, M. D. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.06.004 · Cited by 14
“…reported among users of illicit opioids, methadone and buprenorphine; however, several cross-sectional reports demonstrated that buprenorphine users had consistently lower levels of dysfunction when compared to other opioids (Bliesener et al., 2005; Hallinan et al., 2008; Quaglio et al., 2008).”
BackgroundOpioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men
Goletiani, N. V., Mendelson, J. H., Sholar, M. B., Siegel, A. J., & Mello, N. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.007 · Cited by 14
“In addition, methadone dose-dependently reduced testosterone levels in methadone-maintained heroin addicts (Bliesener et al., 2005; Hallinan et al., 2008; Mendelson et al., 1976) and in chronic heroin users (Celani et al., 1984; Mendelson et al., 1980; Mendelson and Mello, 1982, 1975; Mendelson et…”
BackgroundInfluentialWebster, L. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6974-2_4 · Cited by 13
“Methadone has been associated with hypogonadism, primarily through studies of methadone maintenance therapy in people with opiate dependence [ 34 , 37 ].”
BackgroundResultBeştepe, E. E., Tunalı, N., & Sarıdoğan, G. E. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s276708 · Cited by 13
Gonadotoxic effect of tramadol administration: A prospective controlled study
Soliman, T., Shaher, H., Mohey, A., El‐Shaer, W., & Sebaey, A. (2021) · Arab Journal of Urology · doi:10.1080/2090598x.2021.2002634 · Cited by 12
“Opioids and tramadol as an opioid may have negative effects on libido, and erectile function (EF) and ejaculatory function [11,12].”
BackgroundRamli, F. F., Azizi, M. H., & Hashim, S. A. S. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.57641 · Cited by 11
“studies also reported the association between hypogonadism and sexual dysfunction in patients receiving opioids [12].”
ResultTherapeutic Utility of Opioids for Restless Legs Syndrome
Mackie, S. E., & Winkelman, J. W. (2017) · Drugs · doi:10.1007/s40265-017-0773-6 · Cited by 11
“[38] and Cushman and Kreek [39]), a recent systematic review synthesizing 12 controlled studies of opioids used for therapeutic purposes indicated that the effect is not specific to this drug [40].”
BackgroundAghamohammadhasani, P., Mokhtaree, M., Nazari, A., & Rahnama, A. (2018) · PubMed Central · doi:10.22122/ahj.v10i2.540 · Cited by 11
Management of cancer pain: challenging the evidence of the recent palliative care opioid guidelines
Kurita, G. P., & Sjøgren, P. (2021) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16136 · Cited by 11
Opioid replacement therapy with methadone or buprenorphine effects on male mice reproduction
Moinaddini, F., Amirinejad, M., Haghpanah, T., Esfahlani, M. A., Yoosefi, F., & Nematollahi‐Mahani, S. N. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06274-7 · Cited by 11
“In addition, patients treated with buprenorphine had better erectile function compared with methadone replacement therapy (Bliesener et al. 2005).”
BackgroundBarai, S., Suryawanshi, S. A., & Pandey, A. K. (2009) · PubMed · Cited by 11
FRANCES, R. J. (2006) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70092-6 · Cited by 11
Saper, J. R., & Lake, A. E. (2006) · Headache Currents · doi:10.1111/j.1743-5013.2006.00034.x · Cited by 11
Babaei, H., Sepehri, G., Kheirandish, R., Abshenas, J., & Monshi, M. (2011) · Comparative Clinical Pathology · doi:10.1007/s00580-011-1324-2 · Cited by 10
“They observed that the testosterone level of buprenorphine-treated patients did not differ from that of the healthy controls (Bliesener et al. 2005).”
Vera, F., Zenuto, R. R., Antenucci, C. D., Busso, J. M., & Marin, R. (2011) · Journal of Experimental Zoology Part A Ecological Genetics and Physiology · doi:10.1002/jez.707 · Cited by 10
“…0.28–1.7ng/mL, Cepeda et al., 2006), the extremely aggressive blind mole rats Spalax ehrenbergi (laboratory data: 0.98–2.93 ng/mL, Gottreich et al., 2000) and other mammalian species in general (see Gustafson and Shemesh, ’76; Goymann et al., 2001; Bliesener et al., 2005; Ostner et al., 2008).”
BackgroundInfluentialJaafar, N. R. N., Mislan, N., Baharudin, A., Normala, I., ZAKARIA, R. H., Aziz, S. A., & Sidi, H. (2012) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) · Cited by 9
Oka, V. O., Udefa, A. L., Nna, V. U., & Owu, D. U. (2015) · Trends in Medical Research · doi:10.3923/tmr.2015.51.62 · Cited by 9
“Some studies have demonstrated that chronic administration of these medications may be toxic to male reproductive tissues (Bliesener et al., 2005; Cacciola et al., 2008; Al-Fartosi, 2009) and the liver (Eweka and Eweka, 2011; Nna et al., 2015a), among other toxic effects.”
BackgroundDeji, C., Li, Y., Chen, Y., Lai, J., & Wei, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135677 · Cited by 9
Silva, M. J., Coffee, Z. H., Goza, J., & Rumrill, K. (2022) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2022.2049422 · Cited by 9
“, Buprenorphine is a partial mu agonist opioid that offers a superior safety profile compared to full mu agonist opioids for respiratory depression (15), addiction potential (15), hypogonadism (16, 17), immune compromise (18), and hyperalgesia (19).”
BackgroundBuprenorphine for Cancer Pain: Is It Ready for Prime Time?
Prommer, E. (2014) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909114547227 · Cited by 9
“Buprenorphine has less effects on androgen levels than methadone.(62)”
BackgroundBuprenorphine-induced Symptomatic Hypogonadism in Men: Case Reports and Discussion
Colameco, S., Coren, J. S., & Zimmerman, D. J. (2008) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e318172d612 · Cited by 9
Psychosexual disorders: A cross-sectional study among opioid-dependent individuals
Sethi, M. S., Sareen, H., Sharma, B., & Atter, P. (2017) · Indian Journal of Social Psychiatry · doi:10.4103/0971-9962.214602 · Cited by 9
Hosseini, S. Y., Amini, E., Safarinejad, M. R., Soleimani, M., Lashay, A., & Farokhpey, A. H. (2012) · Urology · doi:10.1016/j.urology.2012.04.006 · Cited by 9
Polygon: The many sides to Australian opioid pharmacotherapy maintenance system
Ritter, A., & Chalmers, J. (2009) · UNSWorks (UNSW Sydney) · doi:10.26190/unsworks/26145 · Cited by 9
Kafel, H., Braga‐Basaria, M., & Basaria, S. S. (2025) · Andrology · doi:10.1111/andr.70013 · Cited by 8
“Similarly, μ opioid agonists, such as fentanyl and methadone, are more likely to suppress the HPG axis compared with partial μ agonists (such as buprenorphine and tapentadol) 44,45 (Figure 3).”
Guideline for Physicians Working in California Opioid Treatment Programs
Stephenson, D. K. (2005) · Cited by 8
Abou-Kassem, D., Kurita, G. P., Sjøgren, P., & Diasso, P. D. K. (2022) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0196 · Cited by 7
Martin, C. E., Parlier‐Ahmad, A. B., Beck, L., Jain, V., & Terplan, M. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2076873 · Cited by 7
“If men have been included, a main research focus has been on the pharmacological effects of medication treatment on sexual health (Bliesener et al., 2005).”
BackgroundPositive association of personal distress with testosterone in opiate-addicted patients
Stange, K., Krüger, M., Janke, E., Lichtinghagen, R., Bleich, S., Hillemacher, T., & Heberlein, A. (2017) · Journal of Addictive Diseases · doi:10.1080/10550887.2017.1303980 · Cited by 7
GAD1 but not GAD2 polymorphisms are associated with heroin addiction phenotypes
Shi, Y., Li, Y., Zhang, J., Xiao, Y., Yan, P., & Zhu, Y. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134704 · Cited by 7
Haddadi, M. R., Ai, J., Shirian, S., Kadivar, A., & Farahmandfar, M. (2019) · Comparative Clinical Pathology · doi:10.1007/s00580-019-03054-2 · Cited by 7
“…Research Center, Tehran, Iran 6 Department of Clinical Science, Faculty of Veterinary Medicine, Shahrekord University, Shahrekord, Iran apparent discrepancies in the literature in terms of hormonal changes in methadone and buprenorphine-treated patients (Yee et al. 2018; Bliesener et al. 2005).”
BackgroundMattia, C., Luongo, L., Innamorato, M. A., Melis, L., Sofia, M., Zappi, L., & Puntillo, F. (2021) · Journal of Pain Research · doi:10.2147/jpr.s314206 · Cited by 7
A Case Series of Abuse of a New Opioid Combination, Norjizak
Siavash, M., Janghorbani, M., Gheshlaghi, F., Adeli, S. H., Saljoughi, M., Moradi, F., & Majidinezhad, M. (2009) · Journal of Addictive Diseases · doi:10.1080/10550880902772928 · Cited by 7
Salehi, M., Barekatain, M., Faghani, F., Karimian, N., Molaeinezhad, M., Asadalloahi, G. A., & Maracy, M. R. (2015) · Sexual & Relationship Therapy · doi:10.1080/14681994.2015.1016494 · Cited by 7
“There are also several studies examining the relationship between narcotics such as methadone and serum testosterone level in other countries (Bliesener et al., 2005; Brown et al., 2005; Hallinan et al., 2008, 2009).”
BackgroundEndocrine Adverse Effects of Long-Term Opioid Use
Bogler, O., & Incze, M. A. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.0863 · Cited by 6
Zhong, B., Xu, Y., Zhu, J.-H., & Li, H. (2018) · Journal of Pain Research · doi:10.2147/jpr.s177564 · Cited by 6
“However, there is evidence that, compared to buprenorphine maintenance treatment, MMT is associated with higher likelihood of sexual side effects.(38) Sexual dysfunction in methadone-maintained patients can be directly induced by methadone.”
BackgroundThe ANDOPIO Study Group, Ruiz, J. J., Delgado, J. M. M., & García‐Marchena, N. (2021) · Harm Reduction Journal · doi:10.1186/s12954-021-00488-2 · Cited by 6
“Based on their pharmacological action the methadone is likely to produce an intense inhibition of the sexual performance than buprenorphine [55].”
BackgroundMcGuirt, A. F., & Brezing, C. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2023.2292012 · Cited by 6
Hindawy, R. F., hendawy, F. F., & Ali, N. (2019) · Zagazig Journal of Forensic Medicine · doi:10.21608/zjfm.2019.11496.1028 · Cited by 6
Cobos, J. P. D. L., Alcaraz, S., Siñol, N., González‐Sáiz, F., Vergara‐Moragues, E., & Trujols, J. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108010 · Cited by 6
Żylicz, Z. (2009) · Advances in Palliative Medicine · Cited by 5
Erectile Dysfunction and Methadone Maintenance Therapy
Mohamed, I. N. (2020) · Medicine & health · doi:10.17576/mh.2020.1501.02 · Cited by 5
Transdermal buprenorphine for pain management in children
Attinà, G., Romano, A., Triarico, S., Mastrangelo, S., Maurizi, P., & Ruggiero, A. (2021) · Drugs in Context · doi:10.7573/dic.2021-6-1 · Cited by 5
Sexual Function and Alcohol and Other Drug Use
Hallinan, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_85 · Cited by 5
Medication Treatments for Opioid Use Disorder: What Is the Impact on Mood and Mood Disorders?
Hassan, A. N., & Nunes, E. V. (2018) · Current Addiction Reports · doi:10.1007/s40429-018-0215-x · Cited by 5
Painful Multi-Symptom Disorders: A Systems Perspective
Chapman, C. R. (2009) · Frontiers in neuroscience · doi:10.1201/9781439812105-c1 · Cited by 5
Assessing men with opioid use disorder for testosterone deficiency after the development of symptoms
Bali, B., Tuan, W., Scott, A. R., Bollampally, P., Groff, D., Leong, S. L., King, V. L., & Bone, C. (2024) · Journal of Addictive Diseases · doi:10.1080/10550887.2024.2327751 · Cited by 4
“31,37 (3) Testosterone replacement may also be an appealing option for some patients.”
Therapeutic levels of short-term tramadol administration negatively affect testis function in rats
Aprioku, J. S., Okpe, B. T., & Ben, D. (2021) · Asian Pacific Journal of Reproduction · doi:10.4103/2305-0500.306435 · Cited by 4
Buprenorphine: Side Effects and Tolerability
Washington, T. A., & Fanciullo, G. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6974-2_14 · Cited by 4
“In a different study of 17 men on maintenance buprenorphine, 37 on methadone, and 51 healthy blood donors, testosterone levels were higher in the buprenorphine as compared with the methadone group [ 46 ].”
BackgroundDrugs that Affect Sexual Function
Alphs, H. H., & McVary, K. T. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-536-1_7 · Cited by 4
“While the degree of sexual dysfunction appears to be less [38], buprenorphine, a newer drug used in the treatment opioid dependence, has also been shown to suppress levels of testosterone, luteinizing hormone, and estradiol [39, 40].”
BackgroundBhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · Cited by 4
Roantree, E., & Żylicz, Z. (2009) · Advances in Palliative Medicine · Cited by 4
Hypogonadism and Low Testosterone Levels as a Side Effect of Methadone and Buprenorphine
Fareed, A. (2012) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.6539 · Cited by 4
“2012; 1(2) Fareed A Effects of Methadone and Buprenorphine on Rat Testis”
BackgroundSzucs-Reed, R. P., & Gallagher, R. M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1651-8_29 · Cited by 4
Mohamed, H., & Mohamed, H. K. (2020) · The Egyptian Journal of Histology · doi:10.21608/ejh.2020.24408.1251 · Cited by 3
“, 2005[29] who recorded that the tramadol effect on the gonadotropin-releasing hormone was by the increased levels of prolactin.”
BackgroundThe effect of opium dependency on testis volume: a case-control study.
Cyrus, A., Solhi, H., Farahani, M. A., Vishteh, H. R. K., Goudarzi, D., Mosayebi, G., & Mohamadian, H. (2012) · Europe PMC (PubMed Central) · Cited by 3
Banwell, C. L., Dance, P., Olsen, A., & Dixon, J. (2009) · ANU Open Research (Australian National University) · Cited by 3
Sexual Dysfunction in Persons Receiving Opioid Substitution Therapy
Xu, P. J., Choi, E. J., El‐Khatib, F. M., Choe, E., & Yafi, F. A. (2020) · Current Sexual Health Reports · doi:10.1007/s11930-020-00282-4 · Cited by 3
Sexual Function and Alcohol and Other Drug Use
Hallinan, R. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_142 · Cited by 3
A Case of Hypogonadotropic Hypogonadism Caused by Opioid Treatment for Nonmalignant Chronic Pain
Tabuchi, Y., Yasuda, T., Kaneto, H., Kitamura, T., Kozawa, J., Otsuki, M., Imagawa, A., Nakae, A., Matsuda, Y., Uematsu, H., et al. (2012) · Case Reports in Medicine · doi:10.1155/2012/740603 · Cited by 3
“It has been reported that buprenorphine has lower incidence of hypogonadism compared to other opioids [17, 44].”
Taramsari, M. R., Badsar, A., Falahatkar, S., Movassagh, H., Karkan, M. F., Montazeri, S., & Molazade, H. (2014) · Iranian Journal of Toxicology · Cited by 3
Lauzon, P. (2012) · Drogues santé et société · doi:10.7202/1007848ar · Cited by 3
State-of-The-Art Treatment of Opioid Use Disorder
Mooney, L. J., & Saxon, A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54856-4.00006-7 · Cited by 3
van Rysewyk, S. P. (2013) · UTAS Research Repository · doi:10.25959/23208842 · Cited by 3
Patel, V., Rao, R., Bhad, R., Mishra, A. K., Quraishi, R., & Gupta, Y. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1525_2025 · Cited by 2
“…prolactin profile in our cohort may reflect the lower suppressive potential of short-acting heroin compared to long-acting opioids (such as methadone and buprenorphine), unknown purity, as well as the relative low sensitivity of the pituitary to its effects compared to the hypothalamus 36 , 39 .”
Wirz, S., Schenk, M., & Kieselbach, K. (2022) · Der Schmerz · doi:10.1007/s00482-022-00655-9 · Cited by 2
Comparing sexual dysfunction in maintenance therapy with Methadone and Buprenorphine in married male
Hassanipour, S., Arab‐Zozani, M., Maghsoudi, A., Mokhtari, A. M., & Rad, R. G. (2016) · International journal of epidemiologic research · Cited by 2
OPIUM AND ITS MAJOR ALKALOIDAL CONSTITUENTS: A REVIEW ARTICLE
Devi, R., Khan, B., Bala, M., Pathania, K., & Thakur, K. (2022) · YMER Digital · doi:10.37896/ymer21.07/20 · Cited by 2
Kotlińska–Lemieszek, A. (2022) · Medycyna Paliatywna · doi:10.5114/pm.2022.126738 · Cited by 2
Hassan, M. H., Saadeldin, A. A., Alsagheer, G. A., Desoky, T., & Hasan, A. S. (2023) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-023-01141-4 · Cited by 2
“In tramadol abusers, hyperprolactinemia lowers testosterone levels and may have an impact on male fertility either directly by lowering testosterone synthesis or indirectly by inhibiting GnRH release [34, 35].”
Eltohamy, E. A., Hassan, A. M., El-Garhy, H. A. S., & Serag, A. M. (2023) · Journal of Agricultural Chemistry and Biotechnology · doi:10.21608/jacb.2023.228192.1063 · Cited by 2
Sexual Dysfunctions - Special Issues
(2011) · InTech eBooks · doi:10.5772/1316 · Cited by 2
“One previous study found that buprenorphine has fewer negative effects on male sexual performance than methadone (Bliesener et al., 2005).”
BackgroundEndocrine Manifestations of Alcohol and Other Drug Use Disorders
Quirk, A. R., & Twigg, S. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_84 · Cited by 2
Geschlechtsunterschiede bei der psychopharmakologischen Behandlung psychiatrischer Erkrankungen
Bäwert, A., Winklbaur, B., Metz, V., Fischer, G., & Einleitung, Ñ. (2009) · Blickpunkt der Mann · Cited by 2
Antiandrogene Wirkungen von Opioiden
Wirz, S. (2021) · Schmerzmedizin · doi:10.1007/s00940-021-3226-y · Cited by 2
Seyed Hassan Hejazian, M. H. D. (2007) · Bioline International (Bioline International) · Cited by 2
Health Care Utilization and Morbidity Associated With Methadone and Buprenorphine Treatment
Bell, J. R., & Butler, B. (2010) · Cited by 2
Does Methadone Prolong QTc Intervals by Depleting Testosterone Levels?
Daniell, H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.282 · Cited by 2
Psychological Factors Associated With Sexual Dysfunction in Men on Methadone Maintenance Treatment
Bakhshani, N., Karimi, Z., Mojahed, A., Arani, M. J. L., & Ayubi, E. (2022) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba-118838 · Cited by 1
“Several human studies have shown the association between hypogonadism and sexual dysfunction in opioid patients (13).”
BackgroundMeyer, M., Westenberg, J. N., Brunner, P., Gürtler, M., Wiesbeck, G. A., Lang, U. E., Vogel, M., & Dürsteler, K. M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1204236 · Cited by 1
Erectile dysfunction in men treated in opioid addiction treatment programs
Segrec, N., & Erčulj, V. I. (2025) · Heroin addiction and related clinical problems · doi:10.62401/2531-4122-2025-3 · Cited by 1
Fornasari, D., & Cuomo, A. (2025) · Pain and Therapy · doi:10.1007/s40122-025-00753-3 · Cited by 1
“In conclusion, these clinical studies suggest that buprenorphine administration is an effective, long-term option for pain management [105, 107], with a reduced risk of developing sexual dysfunctions associated with the treatment [121].”
Michaud, L., Guţă, A., Perri, M., Schaff, A. M., Boyle, M., King, K., Strıke, C., & Kolla, G. (2026) · Harm Reduction Journal · doi:10.1186/s12954-026-01409-x · Cited by 1
“…(and limited medical management) of side effects, particularly in the case of methadone, including muscle and bone aches, tooth decay and dental problems, constipation, testosterone deficiency, sexual dysfunction, as well as cardiovascular and neuro-behav-ioural symptoms [53, 64, 78, 79].”
Endocrinopathies and Their Recovery in a 20‐Year Cohort Study of People With Heroin Dependence
Tremonti, C., Twigg, S., Mills, K. L., Marel, C., Teesson, M., & Haber, P. (2026) · Clinical Endocrinology · doi:10.1111/cen.70109 · Cited by 1
“A 2005 German study found no correlation between depression scores and testosterone levels in men taking methadone [29], whereas a 2004 American study reported higher rates of both depression and hypogonadism among male cancer survivors prescribed opioids compared with those opioid‐free [30].”
Endocrine Manifestations of Addictive Diseases
Hallinan, R. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_123 · Cited by 1
Substance, Drugs, Sexual dysfunction, erectile dysfunction,
Mehtry, V., Kiran, K., Shetty, N. J., Bhandary, S., Adappa, K. K., Soans, S., Maben, E. V. S., & Hegde, A. N. (2013) · Cited by 1
Buprenorfina w plastrach. Szereg odpowiedzi na dręczące pytania
Żylicz, Z. (2012) · Palliative Medicine in Practice · Cited by 1
Farag, R. S., Nawawy, M. A. E., Fathy, W. M., & Atiaa, H. (2013) · INTERNATIONAL JOURNAL OF COMPUTERS & TECHNOLOGY · doi:10.24297/ijct.v11i9.3411 · Cited by 1
“[16] Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmuller D 2005.”
Background
Metadata
- Authors
- Bliesener, N., Albrecht, S., Schwager, A., Weckbecker, K., Lichtermann, D., & Klingmüller, D.
- Affiliations
- University of Bonn (DE)
- ORCID
- Weckbecker, Klaus
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-01
- Volume
- 90
- Issue
- 1
- Pages
- 203-206
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2164669880
- Semantic Scholar
- 6b922b7d804a6488ee6c5032a29f420570446a72
- Cited by
- 236
- References
- 14
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 5 · 2022: 15 · 2021: 13 · 2020: 9 · 2019: 16 · 2018: 15 · 2017: 11 · 2016: 15 · 2015: 8 · 2014: 14 · 2013: 16 · 2012: 16
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- buprenorphine, methadone, opioid use disorder, testosterone, sexual dysfunction, hypogonadism, heroin addiction, gonadal axis, depression, gonadotropins, prolactin, estradiol, sex hormone-binding globulin
- MeSH terms
- Adult, Buprenorphine, Estradiol, Humans, Male, Methadone, Opioid-Related Disorders, Sexual Behavior, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.